G-protein-coupled receptors in aldosterone-producing adenomas: a potential cause of hyperaldosteronism.

The source of aldosterone in 30-40% of patients with primary hyperaldosteronism (PA) is unilateral aldosterone-producing adenoma (APA). The mechanisms causing elevated aldosterone production in APA are unknown. Herein, we examined the expression of G-protein-coupled receptors (GPCRs) in APA and demonstrated that when compared with normal adrenals, there is a general elevation of certain GPCR in many APA and/or ectopic expression of GPCR in others. RNA samples from normal adrenals (n = 5), APAs (n = 10), and cortisol-producing adenomas (CPAs; n = 13) were used on 15 genomic expression arrays, each of which included 223 GPCR transcripts presented in at least 1 out of 15 of the independent microarrays. The array results were confirmed using real-time RT-PCR (qPCR). Four GPCR transcripts exhibited a statistically significant increase that was greater than threefold when compared with normal adrenals, suggesting a general increase in expression when compared with normal adrenal glands. Four GPCR transcripts exhibited a > 15-fold increase of expression in one or more of the APA samples when compared with normal adrenals. qPCR analysis confirmed array data and found the receptors with the highest fold increase in APA expression to be LH receptor, serotonin receptor 4, GnRH receptor, glutamate receptor metabotropic 3, endothelin receptor type B-like protein, and ACTH receptor. There are also sporadic increased expressions of these genes in the CPAs. Together, these findings suggest a potential role of altered GPCR expression in many cases of PA and provide candidate GPCR for further study.

[1]  C. Tortorella,et al.  Endothelin-1 stimulates aldosterone synthesis in Conn's adenomas via both A and B receptors coupled with the protein kinase C- and cyclooxygenase-dependent signaling pathways. , 2000, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.

[2]  Takashi Suzuki,et al.  A case of normoreninemic aldosterone-producing adenoma associated with chronic renal failure , 2003, Endocrine.

[3]  W. Oelkers,et al.  Dose-response relationships between plasma adrenocorticotropin (ACTH), cortisol, aldosterone, and 18-hydroxycorticosterone after injection of ACTH-(1-39) or human corticotropin-releasing hormone in man. , 1988, The Journal of clinical endocrinology and metabolism.

[4]  M. Chavarri,et al.  Transient fall and subsequent return of high aldosterone secretion by adrenal adenoma during continued dexamethasone administration. , 1977, The Journal of clinical endocrinology and metabolism.

[5]  J. Olefsky,et al.  Involvement of both G(q/11) and G(s) proteins in gonadotropin-releasing hormone receptor-mediated signaling in L beta T2 cells. , 2002, The Journal of biological chemistry.

[6]  P. Bernante,et al.  Adiponectin receptor expression in the human adrenal cortex and aldosterone-producing adenomas. , 2006, International journal of molecular medicine.

[7]  H. Vaudry,et al.  Effect of Serotonin4 (5-HT4) Receptor Agonists on Aldosterone Secretion in Idiopathic Hyperaldosteronism , 2000, Endocrine research.

[8]  R. Millar.  GnRHs and GnRH receptors. , 2005, Animal reproduction science.

[9]  O. Chabre,et al.  Ectopic expression of the gastric inhibitory polypeptide receptor gene is a sufficient genetic event to induce benign adrenocortical tumor in a xenotransplantation model. , 2006, Endocrinology.

[10]  N. Hattori,et al.  An Unfolded Putative Transmembrane Polypeptide, which Can Lead to Endoplasmic Reticulum Stress, Is a Substrate of Parkin , 2001, Cell.

[11]  A. J. Man in't veld,et al.  ACTH-dependent aldosterone excess due to adrenocortical adenoma: a variant of primary aldosteronism. , 1978, The Journal of clinical endocrinology and metabolism.

[12]  T. Mune,et al.  Eutopic overexpression of vasopressin v1a receptor in adrenocorticotropin-independent macronodular adrenal hyperplasia. , 2002, The Journal of clinical endocrinology and metabolism.

[13]  G. Tocchini-Valentini,et al.  Molecular cloning and chromosomal localization of the mouse Gpr37 gene encoding an orphan G-protein-coupled peptide receptor expressed in brain and testis. , 1998, Genomics.

[14]  W. Rzeski,et al.  Glutamate antagonists limit tumor growth. , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[15]  R. Gordon.  Primary aldosteronism--actual epidemics or false alarm? , 2004, Arquivos brasileiros de endocrinologia e metabologia.

[16]  G. Tocchini-Valentini,et al.  Altered dopamine signaling and MPTP resistance in mice lacking the Parkinson's disease-associated GPR37/parkin-associated endothelin-like receptor. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[17]  W. Hoefnagels,et al.  Nocturnal, daytime, and postural changes of plasma aldosterone before and during dexamethasone in adenomatous and idiopathic aldosteronism. , 1980, The Journal of clinical endocrinology and metabolism.

[18]  H. Vaudry,et al.  Evidence for a role of vasopressin in the control of aldosterone secretion in primary aldosteronism: in vitro and in vivo studies. , 2006, The Journal of clinical endocrinology and metabolism.

[19]  W. Oelkers,et al.  The effect of chronic low-dose infusion of ACTH (1-24) on renin, renin-substrate, aldosterone and other corticosteroids in sodium replete and deplete man. , 1980, Acta endocrinologica.

[20]  A. Lacroix,et al.  Aberrant Expression of Hormone Receptors in Adrenal Cushing's Syndrome , 2005, Pituitary.

[21]  D. Rizzoni,et al.  Renal Damage in Primary Aldosteronism: Results of the PAPY Study , 2006, Hypertension.

[22]  R. Farese,et al.  Treatment of primary cultures of calf adrenal glomerulosa cells with adrenocorticotropin (ACTH) and phorbol esters: a comparative study of the effects on aldosterone production and ACTH signaling system. , 1990, Endocrinology.

[23]  J. Mathis,et al.  Quantitative assessment of CYP11B1 and CYP11B2 expression in aldosterone-producing adenomas. , 2002, European journal of endocrinology.

[24]  J. Soares,et al.  Presence of a Gs alpha mutation in an adrenal tumor expressing LH/hCG receptors and clinically associated with Cushing's syndrome. , 2000, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[25]  G. Vinson,et al.  Studies on the mechanisms of ACTH-induced inhibition of aldosterone biosynthesis in the rat adrenal cortex. , 1989, The Journal of endocrinology.

[26]  A. Spiegel,et al.  Defects in G protein-coupled signal transduction in human disease. , 1996, Annual review of physiology.

[27]  P. Leung,et al.  Expression and transcriptional regulation of the GnRH receptor gene in human neuronal cells. , 2005, Molecular human reproduction.

[28]  F. Beuschlein,et al.  Angiotensin II type 1 receptor and ACTH receptor expression in human adrenocortical neoplasms , 2001, Clinical endocrinology.

[29]  A. Pessina,et al.  Endothelin-1 and the adrenal gland. , 2000, Journal of cardiovascular pharmacology.

[30]  P. Hamet,et al.  Cushing's syndrome variants secondary to aberrant hormone receptors , 2004, Trends in Endocrinology & Metabolism.

[31]  J. Soares,et al.  Presence of a Gsα mutation in an adrenal tumor expressing LH/hCG receptors and clinically associated with Cushing's syndrome , 2000 .

[32]  J. Olefsky,et al.  Involvement of Both Gq/11 and Gs Proteins in Gonadotropin-releasing Hormone Receptor-mediated Signaling in LβT2 Cells* , 2002, The Journal of Biological Chemistry.

[33]  D. Armanini,et al.  Effect of ketanserin in primary aldosteronism. , 1985, Journal of Cardiovascular Pharmacology.

[34]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[35]  P. Meltzer,et al.  Melanoma mouse model implicates metabotropic glutamate signaling in melanocytic neoplasia , 2003, Nature Genetics.

[36]  R. Jung,et al.  High prevalence of primary aldosteronism in the Tayside hypertension clinic population , 2000, Journal of Human Hypertension.

[37]  K. Ronacher,et al.  Regulation of Expression of Mammalian Gonadotrophin‐Releasing Hormone Receptor Genes , 2005, Journal of neuroendocrinology.

[38]  P. Beck‐Peccoz,et al.  Assessing the presence of abnormal regulation of cortisol secretion by membrane hormone receptors: in vivo and in vitro studies in patients with functioning and non-functioning adrenal adenoma. , 2004, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[39]  L. Weinstein,et al.  Inherited diseases involving g proteins and g protein-coupled receptors. , 2004, Annual review of medicine.

[40]  A. Pessina,et al.  Dynamic testing with high-dose adrenocorticotrophic hormone does not improve lateralization of aldosterone oversecretion in primary aldosteronism patients , 2006, Journal of hypertension.

[41]  Y Anouar,et al.  Pharmacological and molecular characterization of 5-hydroxytryptamine(7) receptors in the rat adrenal gland. , 1999, Molecular pharmacology.

[42]  P. Hamet,et al.  Whole genome expression profiling of glucose-dependent insulinotropic peptide (GIP)- and adrenocorticotropin-dependent adrenal hyperplasias reveals novel targets for the study of GIP-dependent Cushing's syndrome. , 2006, The Journal of clinical endocrinology and metabolism.

[43]  G. Arnaldi,et al.  Functional and nonfunctional adrenocortical tumors demonstrate a high responsiveness to low-dose adrenocorticotropin. , 2003, The Journal of clinical endocrinology and metabolism.

[44]  G. Aguilera,et al.  Regulation of adrenal steroidogenesis during chronic stress. , 1996, Endocrine research.

[45]  R. Farese,et al.  ACTH increases de novo synthesis of diacylglycerol and translocates protein kinase C in primary cultures of calf adrenal glomerulosa cells. , 1990, Journal of steroid biochemistry.

[46]  J. Doppman,et al.  Hyperaldosteronism: sampling the adrenal veins. , 1996, Radiology.

[47]  M. Gross,et al.  Suppression of aldosterone by cyproheptadine in idiopathic aldosteronism. , 1981, The New England journal of medicine.

[48]  F. Mitani,et al.  Effects of long term stimulation of ACTH and angiotensin II-secretions on the rat adrenal cortex. , 1996, Endocrine research.

[49]  H. Vaudry,et al.  Characterization of Serotonin4 Receptors in Adrenocortical Aldosterone-Producing Adenomas: In Vivo and in Vitro Studies , 2002 .

[50]  Shuguang Huang,et al.  Overexpression of G protein-coupled receptors in cancer cells: involvement in tumor progression. , 2005, International journal of oncology.

[51]  P. White,et al.  Elevated expression of luteinizing hormone receptor in aldosterone-producing adenomas. , 2006, The Journal of clinical endocrinology and metabolism.

[52]  E. Porteri,et al.  A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. , 2006, Journal of the American College of Cardiology.

[53]  G. Chatellier,et al.  Trends in the prevalence of primary aldosteronism, aldosterone-producing adenomas, and surgically correctable aldosterone-dependent hypertension. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[54]  M. Weinberger,et al.  Primary aldosteronism: diagnosis, localization, and treatment. , 1979, Annals of internal medicine.

[55]  H. Vaudry,et al.  Expression profile of serotonin4 (5-HT4) receptors in adrenocortical aldosterone-producing adenomas. , 2005, European journal of endocrinology.

[56]  K. Shimamatsu,et al.  Analysis of unilateral adrenal hyperplasia with primary aldosteronism from the aspect of messenger ribonucleic acid expression for steroidogenic enzymes: a comparative study with adrenal cortices adhering to aldosterone-producing adenoma. , 2006, Endocrinology.

[57]  K. Catt,et al.  Mediation of Cyclic AMP Signaling by the First Intracellular Loop of the Gonadotropin-releasing Hormone Receptor* , 1998, The Journal of Biological Chemistry.

[58]  G. Arnaldi,et al.  ACTH receptor mRNA in human adrenocortical tumors: overexpression in aldosteronomas. , 1998, Endocrine research.

[59]  J. Funder.  MINERALOCORTICOIDS AND CARDIAC FIBROSIS: THE DECADE IN REVIEW , 2001, Clinical and experimental pharmacology & physiology.

[60]  J. Tait,et al.  The effect of serotonin and potassium on corticosterone and aldosterone production by isolated zona glomerulosa cells of the rat adrenal cortex. , 1972, Australian Journal of Experimental Biology and Medical Science.

[61]  G. Arnaldi,et al.  0021-972X/05/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 90(9):5446–5455 Printed in U.S.A. Copyright © 2005 by The Endocrine Society doi: 10.1210/jc.2005-0836 Expression Profiles for Steroidogenic Enzymes in Adrenocortical Disease , 2005 .

[62]  O. Chabre,et al.  Aberrant expression of human luteinizing hormone receptor by adrenocortical cells is sufficient to provoke both hyperplasia and Cushing's syndrome features. , 2006, The Journal of clinical endocrinology and metabolism.

[63]  H. Schaller,et al.  The neuropeptide head activator is a high-affinity ligand for the orphan G-protein-coupled receptor GPR37 , 2006, Journal of Cell Science.

[64]  H. Vaudry,et al.  Paradoxical Inhibitory Effect of Serotonin on Cortisol Production from Adrenocortical Lesions Causing Cushing's Syndrome , 2004, Endocrine research.

[65]  K. Su,et al.  A novel endothelin receptor type-B-like gene enriched in the brain. , 1997, Biochemical and biophysical research communications.